<?xml version="1.0" ?>
<tei>
	<teiHeader>
		<fileDesc xml:id="55001778"/>
	</teiHeader>
	<text xml:lang="en">
		<front>
<lb/>
	<reference>712–717 | Cancer Sci | August 2003 | vol. 94 | no. 8<lb/></reference>
	
	<note type="other"> Oji et al.<lb/></note>

	<docTitle>
	<titlePart>Overexpression of the Wilms&apos; tumor gene WT1 in<lb/> colorectal adenocarcinoma<lb/></titlePart>
	</docTitle>

	<byline>
	<docAuthor>Yusuke Oji,<lb/> 1 Hirofumi Yamamoto,<lb/> 2 Masaya Nomura,<lb/> 3 Yoko Nakano,<lb/> 1 Ai Ikeba,<lb/> 1 Shin-ichi Nakatsuka,<lb/> 4 Sakie Abeno,<lb/> 1<lb/> Eiji Kiyotoh,<lb/> 1 Tanyarat Jomgeow,<lb/> 1 Mitsugu Sekimoto,<lb/> 2 Riichiro Nezu,<lb/> 5 Yukinobu Yoshikawa,<lb/> 3 Yoshifumi Inoue,<lb/> 3<lb/> Naoki Hosen,<lb/> 6 Manabu Kawakami,<lb/> 7 Akihiro Tsuboi,<lb/> 7 Yoshihiro Oka,<lb/> 6 Hiroyasu Ogawa,<lb/> 6 Shigeo Souda,<lb/> 3 Katsuyuki<lb/> Aozasa, 4 Morito Monden 2 and Haruo Sugiyama 1, 7, 8<lb/></docAuthor>
	</byline>

	<byline>
	<affiliation>1 Department of Functional Diagnostic Science, Osaka University Graduate School of Medicine,</affiliation>
	</byline>

	<address>1-7 Yamada-Oka, Suita, Osaka 565-0871;</address>

	<byline>
	<affiliation> Departments of<lb/>2 Surgery and Clinical Oncology,4 Pathology, 6 Molecular Medicine,7 Cancer Immunotherapy, Osaka University Graduate School of Medicine,</affiliation>
	</byline>

	<address>2-2 Yamada-Oka,<lb/> Suita, Osaka 565-0871;</address>

	<byline>
	<affiliation>3 Department of Surgery,Nissay Hospital, Nippon Life Saiseikai Foundation,</affiliation>
	</byline>

	<address> 6-3-8 Itachi-bori, Nishi-ku, Osaka, Osaka 550-0012; and<lb/></address>

	<byline>
	<affiliation>5 Department of Surgery,Osaka Rosai Hospital, </affiliation>
	</byline>

	<address>1179-3 Nagasone-cho, Sakai, Osaka 591-8025<lb/></address>

	<note type="submission">(Received February 13, 2003/Revised May 21, 2003/Accepted May 23, 2003)<lb/></note>

	<div type="abstract">Expression of the Wilms&apos; tumor gene WT1 was examined in 59<lb/> cases of colorectal adenocarcinoma to examine the involvement<lb/> of WT1 in tumorigenesis. Quantitative real-time reverse transcrip-<lb/>tion-polymerase chain reaction (RT-PCR) showed that WT1 mRNA<lb/> was expressed in the range from 7.2 ×<lb/> × ×<lb/> ×10<lb/> − − −<lb/> −5 to 4.9 ×<lb/> × ×<lb/> ×10<lb/> − − −<lb/> −1 levels (WT1<lb/> expression level in K562 leukemic cells was defined as 1.0) in all<lb/> (100%) of the 28 cases of colorectal adenocarcinoma examined,<lb/> and that the WT1 mRNA expression levels were higher in 20<lb/> (71%) of the 28 cases compared to those of normal-appearing<lb/> mucosal tissues examined. Immunohistochemical analysis using<lb/> an anti-WT1 antibody was performed on 46 cases of colorectal<lb/> adenocarcinoma (15 of the 28 cases with WT1 mRNA expression<lb/> and 31 newly collected cases), and the expression of WT1 protein<lb/> was detected in 41 (89%) of the 46 cases. The direct sequencing<lb/> analysis of the WT1 genomic DNA showed no mutations in any of<lb/> the 10 exons of the WT1 gene in any of 5 different colorectal ade-<lb/>nocarcinomas. These results may indicate an important role of the<lb/> wild-type WT1 gene in tumorigenesis of colorectal adenocarci-<lb/>noma. (Cancer Sci 2003; 94: 712–717)<lb/> </div>

	<div type="introduction">he Wilms&apos; tumor gene (WT1) was originally isolated as a<lb/> tumor-suppressor gene that was inactivated in a subset of<lb/> Wilms&apos; tumors and mutated in the germline of children with a<lb/> genetic predisposition to this kidney neoplasm of the<lb/> childhood.<lb/> 1–3) The WT1 gene encodes a zinc finger transcription<lb/> factor that regulates transcription of growth factor (PDGF-A<lb/> chain, CSF-1, and IGF-II)<lb/> 4–6) and growth factor receptor (IGF-<lb/>IR)<lb/> 7) genes and other genes (RAR-α, c-myc, and bcl-2).</div>

		</front>
	</text>
</tei>
